The expansion is on track to be completed this year. The new 8,000 square-foot space will mirror Altasciences’ current bioanalytical laboratory in Laval, Québec, with state-of-the-art equipment and bioanalytical capabilities.
The goal is to supplement the service offering already available at Altasciences’ site in Seattle, WA, to support preclinical and clinical studies conducted in the U.S.
The laboratory is near both preclinical and clinical facilities and reflects Altasciences’ focus on ensuring a seamless collaboration between teams, sites, and phases of development.
“We are very excited about the laboratory expansion at our Columbia site,” said Lynne Le Sauteur, vice president, laboratory sciences, at Altasciences. “With this additional full-service, state-of-the-art bioanalytical and flow cytometry laboratory, we look forward to continuing to provide our usual high-quality, timely analyses of study samples for our clients.”
The Columbia site is near the fast-growing university town that is easily accessible from across the country. The bioanalytical laboratory will contain 48 workbenches in an open space, with services that include mass spectrometry and ligand binding assays, flow cytometry, biomarkers, as well as cell culture.
Andy Brown, Columbia site director, at Altasciences said: “At Altasciences, we continue to increase capacity in support of our strategic growth plan and look forward to the completion of this new laboratory to supplement our existing North American service offering.”
